Select therapeutic use:
Indications for BAYRHO-D MINI-DOSE:
Prevention of Rho(D) sensitization following termination of pregnancies up to 12 weeks gestation.
Each syringe (approx. 50mcg) prevents sensitization to 2.5mL of Rh positive red blood cells. Give IM up to 12 weeks' gestation, within 3 hours of an Rh incompatible delivery, miscarriage, or abortion.
Rho(D) positive patients. Pregnancy (Cat.C).
Live vaccines. Have epinephrine available.
Full Dose (single-dose syringes and vials)—1, 10; Mini-Dose (single-dose syringes)—10